[Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection].

ABSTRACT:

Introduction

Hypertension has been associated with worse outcomes in patients with COVID-19 infection, so concerns have been raised about the possibility that inhibitors of the renin-angiotensin system (RAS) could influence the prognosis of these patients.

Methods

This is an observational study of 921 consecutive patients admitted with COVID-19 respiratory infection to Hospital General Universitario Ciudad Real from March 1 to April 30, 2020. Following data were collected including patient demographic information, medical history, clinical characteristics, laboratory data, therapeutic interventions during the hospitalization and clinical outcomes.

Results

The mean age was 78years, and 59.2% of patients had a history of hypertension. Patients with previous treatment wi

SUBMITTER: Martinez-Del Rio J 

PROVIDER: S-EPMC7381916 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature